BioProtect

Kochav Yair Tzur Yigal, Israel Founded: 2001 • Age: 25 yrs Acquired By Olympus
Radiation protection technology is developed for prostate cancer radiotherapy.

About BioProtect

BioProtect is a Healthcare company based in Kochav Yair Tzur Yigal (Israel) founded in 2001 by Shaul Shohat and Adrian Paz, and was acquired by Olympus in May 2026. Radiation protection technology is developed for prostate cancer radiotherapy. BioProtect has raised $74.1 million across 10 funding rounds from investors including Medtronic, Olympus and European Union. BioProtect offers products and services including BioProtect Balloon Implant System. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its legal entity is BIOPROTECT MEDICAL INC.

Company details

BioProtect was founded in 2001 as a developer of radiation protection solutions in the medical technology sector. The BioProtectProSpace Balloon System has been created to serve as a spacer, displacing healthy tissue from high-dose radiation areas during prostate cancer treatments. Operations focus on advancing radiotherapy accessories, with co-founders Shaul Shohat as CTO and Adrian Paz leading the efforts. No specific geographic base is indicated.

  • Headquarters Kochav Yair Tzur Yigal, Israel
  • Founders Shaul Shohat, Adrian Paz
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bioprotect.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Olympus (May 2026)
  • Legal Name Bioprotect Medical Inc
Key Metrics
  • Total Equity Funding
    $74.1M (USD)

    in 10 rounds

  • Latest Funding Round
    $2.65M (USD), Grant

    Oct 2023

  • Investors
    Medtronic

    & 11 more

  • Acquired by
    Olympus

    (May 2026)

Products & Services of BioProtect

BioProtect offers a comprehensive portfolio of products and services, including BioProtect Balloon Implant System.

BioProtect Balloon Implant System
Medical Device

Biodegradable balloon for spacing rectal wall during prostate radiotherapy.

Apps and channels of BioProtect

its YouTube channel BioProtect has 5 subscribers.

BioProtect
YouTube 5 subscribers Other
Open channel

Funding Insights of BioProtect

BioProtect has successfully raised a total of $74.1M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $2.65 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $74.1M
  • Total Rounds 10
  • Last Round Grant β€” $2.65M
  • First Round $500,000

    (Oct 2004)

  • Investors Count 11

All 10 funding rounds of BioProtect with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2023$2.65MGrant––
Sep 2023$28MSeries E–MVM
Sep 2020$25MSeries D–Vincent Tchenguiz, Almeda Ventures
Jan 2020$13MSeries D–KB Investment, Accelmed Ventures
–
Apr 2017$3.5MSeries A––
–
Sep 2011$700,000Seed–Xenia Venture Capital
–
Jul 2010$750,000Seed––
–
Jun 2008$1.65MSeed–Xenia Venture Capital
–
Feb 2007$1MSeed–Xenia Venture Capital
–
Oct 2004$500,000Seed–Xenia Venture Capital
–
Valuation history

12 investors in total: 11 institutional and 1 angel.

Investors in BioProtect

BioProtect has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Medtronic, Olympus and European Union.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Peregrine is focused on healthcare innovation through strategic global investments.
peregrinevc.comOr Yehuda, Israel
Venture capital fund investing in early-stage tech startups
1990kbic.co.krSeoul, South Korea
Investments in health tech sectors are managed by Almeda Ventures.
almedaventures.comTel Aviv, Israel
Venture capital firm investing in early stage healthcare startups
triventures.vcHerzliya, Israel
accelmed-ventures.com
Early-stage centric life sciences and tech focused VC firm investing primarily in Israel and the US
2003xenia.co.ilTel Aviv, Israel
mvm.com
cbg.uk.com
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Medical equipment for treating over 30 chronic diseases is developed.
1949medtronic.comMinneapolis, United States
Premium access

Investor details for BioProtect

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioProtect

21 people are tracked at BioProtect (9 in leadership, 5 in board & advisors, 7 in team).

NameRoleGroup
Shaul Shohat
Co-Founder & CTOLeadership
Adrian Paz
Co-FounderLeadership
Itay Barnea
CEO At BioprotectLeadership
Lee Adler
Chief Operating OfficerLeadership
Shahar Shaked
VP Finance & AdministrationLeadership
Udi Wexler
Director Of EngineeringLeadership
Derek Webster
Senior Vice President Of SalesLeadership
Arik Tzour, PhD., MBA
Clinical DirectorLeadership
Dafna Carmi-Yinon
VP, Clinical AffairsLeadership
Michal Geva
Board MemberBoard & advisors
Merav Kaye
Board MemberBoard & advisors
Eyal Lifshitz
Board MemberBoard & advisors
Gennadiy Tolstobrov
Board MemberBoard & advisors
Irit Yaniv
Board MemberBoard & advisors
Ofer Weis
Supply Chain ManagerTeam
Ami Jackson
Human Resources ManagerTeam
Dr. med. Monika Hess
Territory Manager - GermanyTeam
Esti Diskin
Clinical EngineerTeam
Brittany Stokes
Sales ManagerTeam
Joel Hix
North Texas Sales ManagerTeam

1 more people are available in the full profile.

Premium access

Complete people profiles for BioProtect

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BioProtect

4 dated milestones of BioProtect across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioProtect is founded.
  2. Funding First funding round of $500K.
  3. Funding Latest funding round, Grant, of $2.6M.
  4. Exit Acquired by Olympus.

Top companies in Imaging Diagnostics

2 companies that operate in the same segment as BioProtect (Imaging Diagnostics) in Israel, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
1999Tirat Carmel, Haifa District, IsraelUSD 574.2 M541
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
2004Jerusalem, Jerusalem District, IsraelUSD 110.72 MUSD 13.02 M165
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioprotect

Premium access

Complete news archive for BioProtect

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioProtect

BioProtect was founded in 2001 and raised its 1st funding round 3 years after it was founded.

BioProtect is headquartered in Kochav Yair Tzur Yigal, Israel.

BioProtect is a funded company, having raised a total of $74.1M across 10 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Oct 2004.

BioProtect was founded in 2001 as a developer of radiation protection solutions in the medical technology sector. The BioProtectProSpace Balloon System has been created to serve as a spacer, displacing healthy tissue from high-dose radiation areas during prostate cancer treatments. Operations focus on advancing radiotherapy accessories, with co-founders Shaul Shohat as CTO and Adrian Paz leading the efforts. No specific geographic base is indicated.

BioProtect offers BioProtect Balloon Implant System.

BioProtect has 12 investors. Key investors include Medtronic, Olympus, European Union, KB Investment, and Xenia Venture Capital.

BioProtect operates through Bioprotect Medical Inc.

Yes. BioProtect was acquired by Olympus in May 2026.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available